Statin Therapy in Rheumatoid Arthritis: A Cost-Effectiveness and Value-of-Information Analysis

Author： Bansback Nick   Ara Roberta   Ward Sue   Anis Aslam   Choi Hyon K.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.1, 2009-01, pp. : 25-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of TNF-α-blocking agents in the treatment of rheumatoid arthritis

By Merkesdal Sonja   Ruof Jörg   Mittendorf Thomas   Zeidler Henning  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1881-1886

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness of intensive statin therapy remains debatable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses

By Hoyle Martin  

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 885-892

Blackwell Publishing

Access to resources Recommend Favorite

Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide in Rheumatoid Arthritis in Germany: I. Selected DMARDs and Patient-Related Costs

By Schädlich Peter K.  

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 377-393

Adis International

Access to resources Recommend Favorite

Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency

By Schädlich Peter K.  

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 395-420

Adis International

Access to resources Recommend Favorite